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Objective. To compare and analyze the relevance and applied value of chronic liver disease questionnaire (CLDQ) and Traditional
Chinese Medicine liver disease questionnaire (TCMLDQ) in patients with posthepatitic cirrhosis. Methods. The data of 146 pa-
tients’ scales of CLDQ and TCMLDQ which based on the characteristics of chinese medical symptoms were collected. We made
comparative analysis of the relationship between these two scales by the linear regression model and canonical correlation method
and evaluated the advantages and disadvantages of two scales about its items setting and dimension deﬁnition. Result. There is a
negative correlation in total scores between the two scales and the linear regression equation: CLDQ = 239.38 − 1.232TCMLDQ.
The further canonical correlation analysis was used to analyze the two extracted canonical correlative variables with signiﬁcances
(P<0.05), and the results showed that the overall negative correlation between the two scales mainly came from contributions of
both the four dimensions of TCMLDQ (CS, GSYX, GYPX, and OS) and the ﬁve dimensions of CLDQ (AS, FA, SS, AC, and EF).
Conclusion. These two scales have good consistency in the evaluation of severity and life quality of liver cirrhosis patients, so we
suggested that TCMLDQ can be used to evaluate the severity and life quality of patients with posthepatitic cirrhosis.
1.Background
The questionnaire widely used for assessment of quality of
life has been considered as an eﬀective method for quantiﬁ-
cation, objectiﬁcation, and standardization of clinical data
byWorld HealthOrganization, widelyrecognized byexperts,
which could be also introduced into the study on quantiﬁca-
tion of Traditional Chinese Medicine (TCM) symptoms and
signs [1]. But how to make the scale design in accordance
withTCMtheoryanditsthinkingwaysacceptedbydomestic
and foreign counterparts and well applied is the key problem
to be solved. With selected patients of posthepatitic cirrhosis
as research subjects, referring to the basic ideas from as-
sessment quality of life questionnaire, combining with clini-
cal practice and the results based on the study of laws of
symptoms and signs classiﬁcation [2], our task group had
preliminarily established TCM liver disease questionnaire
(TCMLDQ). Then, through the assessment of both patients
andhealthypeople,TCMLDQhadbeenconﬁrmedwithhigh
reliability, validity, and good sensitivity.2 Evidence-Based Complementary and Alternative Medicine
TCM syndromes are the conclusions to the current
pathological state of disease made on the basis of synthesis
and analysis of information (the body’s own feelings and the
external appearance) obtained by doctor through the four
examinations—inspection, hearing and smelling, inquiring,
and palpating. This puts emphasis on the role of individ-
ual subjective symptoms in the individualized process of
occurrence, development, diagnosis, and treatment of the
disease, grasping life and health overall, which has common
characteristics with quality of life assessment questionnaire,
in order to reﬂect the advantages and thinking ways of the
designofTCMquestionnaireanddiscussthevalueandsigni-
ﬁcance of the questionnaire in life quality assessment. In this
study, linear regression and canonical correlation analysis
methods were used to analyze the comparison of self-deve-
loped TCMLDQ and internationally accepted chronic liver
disease questionnaire [3] (CLDQ) to explore the relevance
between two questionnaires in the evaluation of patient’s
qualityoflifeandsubjectiveclinicalinformationandprovide
evidence for recognition and application in counterparts.
2.MaterialsandMethods
2.1. Questionnaire
2.1.1. CLDQ (Chinese Version) (See [4]). The questionnaire
consists of 6 major categories, 29 questions, and six dimen-
sions as fatigue (FA), activity (AC), emotional function (EF),
a b d o m i n a ls y m p t o m s( A S s ) ,s y s t e m i cs y m p t o m s( S S s ) ,a n d
worry (WO) (Table 1). Severities ranged from very serious to
no symptoms are divided into 7 classes (1 to 7 points score),
and the higher score means the higher quality of life.
2.1.2. TCMLDQ. The questionnaire was self-developed by
task group, based on the entry pool constituted preliminary
analysis of clinical data of 900 patients with posthepatitis
cirrhosis [5]. By pretesting to a little portion of the patients,
entries which are repeated, unclearly described, unreadable,
or with frequency below 5% were modiﬁed or deleted. By
reasoningwithexpertsandreferringtotheCLDQ,TCMLDQ
including 38 entries was formed, of which severities ranked
from no symptoms to continuous lasting were divided into
7 class (1 to 7 points score), and the higher score indicated
the more severe symptoms. By extracting the characteristics
of property related to TCM syndromes (similarity analysis to
the clinical data of 437 patients with posthepatitis cirrhosis),
and combining with the clinical practice and ensuring the
uniqueness of the dimension of each entry, ﬁve dimensions
were classiﬁed as common syndromes (CSs, which show
commonalities of disease), yin deﬁciency of liver and kidney
(GSYX), yang deﬁciency of spleen and kidney (PSYX), liver
depression, and spleen deﬁciency (GYPX) and the other
syndromes (OSs, symptoms which have no speciﬁcities for
classiﬁcation of syndromes) (Table 1).
2.1.3. Evaluating Method for Questionnaire. TCMLDQ and
CLDQ were evaluated simultaneously. The investigators are
trained in the same way and to unify ﬁlling methods and
clarifyrequirement.Thetwoquestionnairesareallself-rating
scalecompletedbythepatientsthemselves,andtheinvestiga-
tors had given the necessary guidance and instructions to the
patients. Score points were marked according to the scoring
instruction.
2.2. Clinical Data. All patients were outpatients and inpa-
tients from Shuguang Hospital and Longhua Hospital aﬃli-
ated toShanghai University of Traditional Chinese Medicine,
Putuo District Center Hospital, and the Shanghai Public
Health Clinical Center during the period from 2007 to 2008.
2.2.1. Recruitment
Inclusion Criteria. These include (1) patients who meet the
diagnostic criteria of liver cirrhosis (according to “Guide to
prevention and treatment of chronic hepatitis B” [6]r e v i s e d
by Liver Diseases Institute, Infectious Diseases institute of
Chinese Medical Association in 2005), age 18 to 70 years old,
maleorfemale;(2)patient’swillingnesstoparticipateinscale
tests; they can fully understand the signiﬁcance of scale in all
the entries; (3) no previous mental illness history and other
psychosomatic disease currently.
Exclusion Criteria. These include (1) patients complicated
with severe diseases of heart, brain, kidney, lung, endocrine,
and hematopoietic system; patients complicated with liver
cancer and other serious hepatobiliary diseases and mental
illness; (2) patients complicated II degree or above hepatic
encephalopathy and severe spontaneous bacterial peritonitis,
gastrointestinalbleeding,andhepatorenalsyndrome;(3)un-
clear history of viral infection and other liver diseases related
with alcohol, drug, genetic, autoimmune, and so on; (4)
women in the period of pregnancy or lactation.
2.2.2. Collection of Clinical Information. A total of 146 pa-
tients(averageage46.54±12.54years)withposthepatiticcir-
rhosis had been adopted, including 76 inpatients and 70 out-
patients; 105 males (average height 171.99±5.25cm, average
weight 67.00 ± 10.82Kg) and 41 female (average height
159.85 ± 3.96cm, average weight 59.58 ± 8.85Kg); 25 cases
with a past history of upper gastrointestinal track bleeding;
72 cases with a history of ascites; 77 cases with child-pugh A
grade; 45 cases with child-pugh B grade; 24 cases with child-
pugh C grade (Table 2).
2.3. Statistical Methods. With SPSS17.0 statistical package,
the reliability and validity of the TCMLDQ were analyzed by
using Cronbach’s α-coeﬃcient and factor analysis. We car-
ried out an analysis for dependencies between total scores of
two scales by using linear regression analysis and introduced
the canonical correlation analysis into studying correlation
of the two sets of variables (i.e., two scales consisting of
diﬀerent dimensions) and giving a quantitative description
of the correlation between two scales.Evidence-Based Complementary and Alternative Medicine 3
Table 1: The questionnaire dimensionality consists of TCMLDQ and CLDQ.
Dimensionality Variable Items Questions
C L D Qt o t a ls c o r e C L D Q 2 9 A S+F A+S S+A C+E F+W O
Abdominal symptoms
(ASs) Y1 3 1,5,17
Fatigue (FA) Y2 5 2,4,8,11,13
Systemic symptoms
(SSs) Y3 5 3,6,21,23,27
Activity (AC) Y4 3 7,9,14
Emotional function
(EF) Y5 8 10,12,15,16,19,20,24,26
Worry (WO) Y6 3 18,22,25,28,29
TCMLDQ total score TCMLDQ 38 CS+ GSYX +GYPX +PSYX+ OS
CS X1 18 1,5,17,18,20,22,24,25,26,27,28,29,30,31,35,36,37,38
GSYX X2 5 2,3,11,12,15
PSYX X31 3 3
GYPX X4 6 4,6,7,8,19,34
OS X5 8 9,10,13,14,16,21,23,32
Table 2: The general information of patients with posthepatitic cirrhosis.
Characteristic Count Proportion
(%)
Patients source
Shuguang Hospital 78 53.42
Longhua Hospital 56 38.36
Putuo District Center Hospital 8 5.48
Shanghai Public Health Clinical
Center 42 . 7 4
Section Outpatient/inpatient 70/76 47.95/52.05
Sex Male 105 71.9
Female 41 28.1
Age (years)
<40 14 9.58
40–60 105 71.92
≥60 27 18.49
Virus infection Hepatitis B virus 143 97.95
Hepatitis C virus 3 2.05
Splenectomy Yes 16 10.95
3. Results
3.1. The Reliability and Validity of the TCMLDQ. This scale
was tested by Cronbach’s analysis the α-coeﬃcient is 0.844
(more than 0.80), which shows that the internal consistency
of entries is good and with high reliability; the assessment of
structuralvalidityofthescalewasanalyzedbyfactoranalysis,
the KMO and Bartlett’s test showed that P value <0.01, so
these data were ﬁt for the factor analysis. According to whe-
ther the latent root being greater than 1, 14 factors were ex-
tracted from 38 entries; the accumulative contribution rate
of total variance is 69.45%. The results show that the scale
has good structural validity.
3.2. Linear Regression Analysis for Total Scores of TCMLDQ
and CLDQ Scale. Linear regression analysis was carried out
for total scores of 146 patients in two scales to establish
regression equation (Table 3, Figure 1).
From Table 3, the linear regression equation can be
drawn: CLD Q = 239.38 − 1.232TCMLDQ shows that the
total scale score between the two linear correlations was sig-
niﬁcantly negatively correlated.
We predicted the total score of CLDQ with that of
TCMLDQ. Individual 95% conﬁdence intervals is a statistic
which reﬂects the prediction eﬀect of regression equation. It
has lower and upper bounds (two predicted total scores of
CLDQ) for the prediction interval of the CLDQ for every4 Evidence-Based Complementary and Alternative Medicine
Table 3: Linear regression equation of total scores of TCMLDQ and CLDQ.
Model
Unstandardized coeﬃcients Standardized
coeﬃcients tP value
95% conﬁdence interval for β
β Std. error Beta Lower
bound
Upper
bound
Constant 239.38 6.750 35.462 0.000 226.039 252.724
TCMLDQ −1.232 0.094 −0.737 −13.069 0.000 −1.418 −1.046
Note: dependent variable: CLDQ total score; TCMLDQ: TCMLDQ total score.
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Figure 1: Linear regression plot of total scores of TCMLDQ and
CLDQ.
single case. Through the equation, we can estimate every pa-
tient’s individual 95% conﬁdence interval of CLDQ and
verify whether the actual observation of CLDQ falls in its
individual 95% conﬁdence interval. The result has shown
that 91.8% of patient’s measured values of the CLDQ fall in
their corresponding intervals, which means there is a good
consistency between TCMLDQ and CLDQ (Figure 2).
3.3. Canonical Correlation Analysis between TCMLDQ and
CLDQ. We carried out canonical correlation analysis bet-
weentwosetsofdimensions,ﬁvedimensionsofTCMLDQas
CS (X1), GSYX (X2), PSYX (X3), GYPX (X4), and OS (X5)
and six dimensions of CLDQ as AS (Y1), FA (Y2), SS (Y3),
AC (Y4), EF (Y5), and WO (Y6).
3.3.1. Correlation Analysis between Various Dimensions of
TCMLDQ and CLDQ. In addition to having no correlation
between X3a n dY2, Y4, Y5, Y6, TCMLDQ, and CLDQ, the
results show negative correlations among the other dimen-
sions (P<0.05) (Table 4).
3.3.2. Extraction of Canonical Correlation CoeﬃcientandTest.
This is to discuss whether there is signiﬁcant correlation
in various canonical variables, that is to extract canonical
correlation coeﬃcients among canonical variables and carry
out hypothesis testing for each pair of canonical correlation
coeﬃcients. The results show that there are ﬁve pairs of
canonical correlation variables; ﬁrst and second pairs have
statistical signiﬁcant correlation (P<0.05), so these two
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Figure 2: CLDQ total score, predicted values and individual 95%
conﬁdence intervals, and TCMLDQ total score line graph. Note:
TCMLDQ: TCMLDQ actual measured total score; CLDQ: CLDQ
actual measured total score; PRE: CLDQ scores predicted by TCM-
LDQ score; UICI: upper bounds of predicted CLDQ individual
95% conﬁdence intervals; LICI: lower bounds of predicted CLDQ
individual 95% conﬁdence intervals.
pairs of canonical correlation variables are selected for
analysis (Table 5).
3.3.3. Standardized Correlation Coeﬃcients between Canoni-
cal Correlation Variables and Variables of X and Y Groups.
These are Standardized correlation coeﬃcients between U
canonical correlation variables and various dimensions of
TCMLDQ (X1t oX5), and between V canonical correlation
variables and various dimensions of CLDQ (Y1t oY6)
(Table 6). The conversion formula of canonical correlation
variable could be written according to 1st to 2nd pairs of
canonical variables.
The formula reﬂects that the contribution of original
variables on canonical variable is determined by the canon-
ical correlation coeﬃcients (i.e., canonical variable loads)
between original variables and canonical variables, that is
to say, the greater the load capacity, the more impacts on
canonical variable by original variable. In accordance with
contribution rate to the ﬁrst pair canonical variable, the
original variables follow in the order of X4, X1, Y1, Y4, and
Y5, Y2, which means liver depression and spleen deﬁciency
syndrome, common syndrome, and other syndrome in
TCMLDQ have the largest contribution to the ﬁrst pair ofEvidence-Based Complementary and Alternative Medicine 5
Table 4: Correlation coeﬃcients between various dimensions of TCMLDQ and CLDQ.
Dimensions Y1 Y2 Y3 Y4 Y5 Y6
X1 −0.5426∗∗ −0.5711∗∗ −0.5904∗∗ −0.5118∗∗ −0.5578∗∗ −0.3695∗∗
X2 −0.2283∗∗ −0.4891∗∗ −0.3352∗∗ −0.2653∗∗ −0.2798∗∗ −0.2001∗
X3 −0.2171∗∗ −0.0839 −0.2145∗∗ −0.1552 −0.0502 −0.1244
X4 −0.6688∗∗ −0.5714∗∗ −0.4349∗∗ −0.6409∗∗ −0.4110∗∗ −0.3430∗∗
X5 −0.2416∗∗ −0.3234∗∗ −0.3532∗∗ −0.2115∗ −0.3203∗∗ −0.1936∗
∗∗Correlation is signiﬁcant at the 0.01 level (2 tailed).
∗Correlation is signiﬁcant at the 0.05 level (2 tailed).
Table 5: Canonical correlation coeﬃcients of variables of TCMLDQ and CLDQ.
Canonical variable Coeﬃcient Wilk’s Chi-square df P value
1( U1a n dV1) 0.812 0.212 215.318 30 0.000
2( U2a n dV2) 0.532 0.624 65.619 20 0.000
3( U3a n dV3) 0.324 0.870 19.418 12 0.079
4( U4a n dV4) 0.166 0.972 3.988 6 0.678
5( U5a n dV5) 0.027 0.999 0.103 2 0.950
Note: U (U1t oU5) stands for extracted canonical correlation variables from a group of X variables (TCMLDQ); V (V1t oV5) stands for extracted canonical
correlation variables from Y (CLDQ).
Table 6: Standardized U and V of canonical correlation variables coeﬃcient table.
Variable 1
Standardized correlation coeﬃcients (U)
Variable 2
Standardized correlation coeﬃcients (V)
U1 U2 U3 U4 U5 V1 V2 V3 V4 V5
X1 0.497 0.749 0.718 0.213 0.814 Y1 0.487 −0.674 0.190 0.111 −0.975
X2 0.038 0.474 0.972 0.522 0.211 Y2 0.222 0.563 −1.233 −0.119 −0.333
X3 0.054 0.122 0.453 0.932 0.030 Y3 0.094 0.712 0.653 −0.708 0.126
X4 0.639 1.056 0.423 0.158 0.341 Y4 0.296 −0.792 0.115 0.073 1.055
X5 0.135 0.324 0.282 0.314 1.157 Y5 0.244 0.438 0.321 1.115 −0.054
Y6 −0.076 0.030 0.122 −0.588 0.372
(1) U1 = 0.497X1 + 0.038X2 + 0.054X3 + 0.639X4 + 0.135X5,
V1 = 0.487Y1 + 0.222Y2 + 0.094Y3 + 0.296Y4 + 0.244Y5 − 0.076Y6.
(2) U2 = 0.749X1 + 0.474X2 + 0.122X3 + 1.056X4 + 0.324X5,
V2 = −0.674Y1 + 0.563Y2 + 0.712Y3 − 0.792Y4 + 0.438Y5 + 0.030Y6.
extracted canonical correlation variable, while abdominal
symptoms, activity, emotional function, and fatigue in
CLDQ have the largest contribution to the second pair of
extracted canonical correlation variable, and the original
variables follow the order of X4, X1, X2, X5, and Y4, Y3,
Y1, Y2, and Y5( c o r r e l a t i o nc o e ﬃcient greater than 0.2 [7]),
which means liver depression and spleen deﬁciency syn-
drome, common syndrome, and yin deﬁciency syndrome of
liver and kidney in TCMLDQ have the larger weight to the
second pair of extracted canonical correlation variable, while
activity, systematic symptoms, abdominal symptoms, fati-
gue, and emotional function in CLDQ have larger contribu-
tion.
4. Discussion
Due to the features of chronic liver diseases—long term, per-
sistent,andrecurrent—thetherapeuticeﬀectscannotsimply
be evaluated by cure, improvement of laboratory makers, or
restoration of normal function, and so forth, in clinic, so
comprehensive evaluations of patients’ subjective feeling and
quality of life were needed. Rating scale or questionnaire is
an eﬀective tool for the assessment of respondents’ subjective
feelings.Subjectivesymptoms(i.e.,thepatient’sself-feelings)
are also the important factors in TCM syndrome diﬀerentia-
tion process, which play a main role in identiﬁcation of TCM
syndromes and evaluation of TCM clinical eﬃcacy. But so
far, a set of objective methods and standards of evaluating
therapeutic eﬀect which can be in line with TCM laws have
not been established by TCM. Therefore, Chinese version
western scales such as SF-36 [8, 9] and CLDQ [4] were used
in evaluation of chronic liver diseases.
However, the introduction of foreign scale to evaluate
the quality of life of Chinese people may cause some misun-
derstandings due to diﬀerent cultural background and living
habits and could not achieve the goal of syndrome classiﬁ-
cation in the thinking way of traditional Chinese medicine.6 Evidence-Based Complementary and Alternative Medicine
For this reason, TCM scholars began referring to psycho-
metric principles and methods to design questionnaires or
scale. But no one of scales had gotten the recognition of
counterparts in clinical practice. Therefore, we had tried to
design TCMLDQ to meet TCM theory and way of thinking
and reﬂect the symptom information and characteristics of
syndromes clas-siﬁcation of posthepatitic cirrhosis, in order
to achieve quan-titative assessment of TCM syndromes in
posthepatitic cir-rhosis.
TCMLDQ involves a total of ﬁve dimensions and 38
entries, common symptoms include 18 entries—fatigue,
hypochondriac pain, bitter mouth, halitosis, nausea, yellow-
ishurine,loosestools,diﬃcultyinfallingasleep,easytowake
up, dreamfulness, nocturnal enuresis, irritability, depression,
skin itching, edema, gum bleeding, epistaxis, and muscle
bleeding; other symptoms include headache, dizziness, eye
soreness, redden and swollen eyes and throat, dry mouth,
belching, dry stool, and night sweating; yin deﬁciency synd-
romes of liver and kidney have backache, limb weakness, dry
eyes, blurred vision, and tinnitus; liver depression and spleen
deﬁciency syndrome consists of hypochondriac discomfort,
abdominal distension, chest and hypochondriac distension,
lower abdominal distension, anorexia, and heavy body and
limbs; spleen-kidney yang deﬁciency includes syndrome of
aversion to cold and cold limbs.
At the beginning of this century, CLDQ was introduced
to evaluate quality of life and clinical eﬀects for patients
with chronic liver disease [10–12], and became a domestic
and international accepted speciﬁc scale for chronic liver
disease, which is used as a reference for the control study
withTCMLDQ.CLDQincludes six dimensions and 29 ques-
tions. To test diﬀerent aspects of life quality of patients with
chronic liver diseases, its fatigue dimensions consist of sense
of fatigue, daytime drowsiness, decreased physical strength,
and so forth. Abdominal symptoms include abdominal dis-
tension, abdominal pain, abdominal discomfort; activity in-
cludes appetite, general weakness, and diet restriction; sys-
temic symptoms include body pain, chest distress, shortness
of breath, muscle cramps, dry mouth, and skin itching; emo-
tional function dimension includes anxiety, unhappiness,
depression, irritability, sleep disorders, and distraction;
worry dimension mainly concentrates on patient’s worry
with the disease. The diﬀerent dimensions or categories have
a certain degree of overlap, of which the diﬀerences in indi-
vidual experience had been fully taken into account.
CLDQisusedtoevaluatethequalityoflife,andtherefore
the higher score means the higher quality of life and the
milder symptoms. TCMLDQ is used to evaluate the severity
ofclinicalsymptoms; thehigherscoremeansthemoresevere
symptoms. So considering the results of linear dependencies
betweentotalscoresofthetwoscalesindicated thattherewas
a signiﬁcantly negative correlated relationship between the
two scales. According to linear relationship between the total
score of the two scales, we use the total score of TCMLDQ
as independent variables to predict the total score of CLDQ
(dependent variable) and make a comparison between pre-
dicted and measured scores. The results indicated that the
predictedandmeasuredscoreshadagoodmatch,andalmost
all observation points were in range of the upper and lower
limits of the ﬁtted values. It means that there is a good con-
sistency between TCMLDQ and CLDQ in evaluating the
severity of symptoms and quality of life of posthepatitis cir-
rhosis.
Forfurtheranalyzingcontributiondegreeofeachdimen-
sion to overall correlation of the two scales, we introduced
the canonical correlation analysis into study of the linear
correlation between two scales. The canonical correlation
analysis is used to study the correlation between two sets of
multivariables and takes each group of variables as a whole
rather than analyzing internal situation in each group of
variables. It includes two groups of variables as a whole to
ﬁnd one or more comprehensive variables (linear combina-
tion of actual observed variables) to replace original vari-
ables, thereby turning the relationship between two sets of
variables into the relationship of a few comprehensive var-
iables (canonical variables), which can fully explore the
related information between two groups of indicators.
Canonical correlation analysis was used to analyze the
correlation between ﬁve dimensions in TCMLDQ and six
dimensions in CLDQ. By analyzing the correlation of two
groups’ dimensions of intersection (interrelations in single
dimension),inadditiontospleen-kidneyyangdeﬁciencyand
fatigue, activity, emotional function, worry having no corre-
lation, the other showed a negative correlation (P<0.05).
Further extracting ﬁve pairs of canonical correlation vari-
ables, the whole relationship of two groups of dimensions
in two scales was analyzed; the overall negative linear cor-
relation mainly comes from negative correlation between the
four dimensions of TCMLDQ as common symptoms, yin
deﬁciency syndromes of liver and kidney, liver depression
and spleen deﬁciency syndrome, other symptoms, and ﬁve
dimensions of CLDQ as abdominal symptoms, fatigue, sys-
temic symptoms, activity, and emotional function (in order
of the priority according to the contribution). However,
dimension of spleen and kidney yang deﬁciency syndrome
in TCMLDQ and dimension of worry in CLDQ have little or
nosigniﬁcantcontributiontotheoverallcorrelationbetween
the two scales.
According to the entries and dimensions of two scales,
it was believed that there are two aspects of the main factor
leading to the results above. First, dimension of spleen-
kidney yang deﬁciency syndrome in TCMLDQ has only one
entry of “chills and cold limbs”; there is no such concepts of
cold feeling in modern medicine, which are unique evalua-
tion indictors of TCM. So there is no corresponding entry
of dimension in CLDQ study, and it is reasonable that this
dimension has no contribution to the negative correlation
between the two scales. Second, we had a lack of attention on
mental, social, and psychological factors in initially prepared
TCMLDQ, did not set up the entries to judge the degree of
anxiety, and only had two entries associated with irritability
and depression. Thus, just like dimension of spleen-kidney
yang deﬁciency syndrome, it is reasonable and realistic that
this dimension has no contribution to the negative correla-
tion between the two scales. Therefore, it can also be proved
that canonical correlation analysis could be applied into
comparison among dimensions of two diﬀerent scales andEvidence-Based Complementary and Alternative Medicine 7
could be promoted in the comparison studies of scales in the
future.
5. Conclusion
According to the results of comparisons between self-deve-
loped TCMLDQ and accepted CLDQ scale, TCMLDQ could
cover most of the CLDQ’s study. They are comparable in
dimensions and consistent in the internal structure. That
means they could explain and reﬂect each other to some
extent, which had also conﬁrmed that there was a certain
rationality for the classiﬁcation of TCM syndromes based on
clinical practice. TCMLDQ described by TCM terms could
reﬂect the quantiﬁcation of TCM syndromes with TCM
characteristics and could also replace CLDQ for the eval-
uation of severity and life quality of patients with chronic
liver disease by continuous improvement and amendments.
With improvement of TCM symptoms and signs scale and
development and application of instruments and equipment
such as tongue diagnosis and pulse-taking diagnosis, it will
further improve the quality and level of TCM syndrome
evaluation.
The study focused on analyzing the relationship between
the two scales and aimed at laying the methodological foun-
dation for international counterparts.
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